Topical Sirolimus 0.1% as Off Label Treatment of Kaposi’s Sarcoma

Vittorio Tancredi; Gaetano Licata; Dario Buononato; Maria Pia Boccellino; Caterina Mariarosaria Giorgio; Giuseppe Argenziano

doi:10.5826/dpc.1403a201

Topical Sirolimus 0.1% as Off Label Treatment of Kaposi’s Sarcoma

Authors

Vittorio Tancredi Dermatology Unit, Department of Mental and Physical Health and Preventive medicine, University of Campania Luigi Vanvitelli Naples, Italy
Gaetano Licata Dermatology Unit, Ospedale S.A. Abate, Trapani, Italy
Dario Buononato Dermatology Unit, Department of Mental and Physical Health and Preventive medicine, University of Campania Luigi Vanvitelli Naples, Italy
Maria Pia Boccellino Dermatology Unit, Department of Mental and Physical Health and Preventive medicine, University of Campania Luigi Vanvitelli Naples, Italy
Caterina Mariarosaria Giorgio Dermatology Unit, Department of Mental and Physical Health and Preventive medicine, University of Campania Luigi Vanvitelli Naples, Italy
Giuseppe Argenziano Dermatology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania Luigi Vanvitelli, Naples, Italy

Keywords:

Sirolimus, Kaposi, angiogenesis

References

Schneider JW, Dittmer DP. Diagnosis and Treatment of Kaposi Sarcoma. Am J Clin Dermatol. 2017 Aug;18(4):529-539. doi: 10.1007/s40257-017-0270-4. PMID: 28324233; PMCID: PMC5509489.

Kang T, Ye FC, Gao SJ, Wang LD. Angiogenesis, Kaposi's Sarcoma and Kaposi's Sarcoma-Associated Herpesvirus. Virol Sin. 2008 Dec 1;23(6):449-458. doi: 10.1007/s12250-008-2998-8. PMID: 19890492; PMCID: PMC2771944.

Stallone G, Infante B, Grandaliano G, Schena FP, Gesualdo L. Kaposi's sarcoma and mTOR: a crossroad between viral infection neoangiogenesis and immunosuppression. Transpl Int. 2008 Sep;21(9):825-32. doi: 10.1111/j.1432-2277.2008.00697.x. Epub 2008 May 22. PMID: 18498314.

Downloads

Published

2024-07-31

Issue

Vol. 14 No. 3 (2024): 2024 Vol 14, No 3 | July

Section

Research Letter

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.

How to Cite

Topical Sirolimus 0.1% as Off Label Treatment of Kaposi’s Sarcoma. Dermatol Pract Concept [Internet]. 2024 Jul. 31 [cited 2024 Dec. 5];14(3):e2024201. Available from: https://www.dpcj.org/index.php/dpc/article/view/4292